Jain Ajai Kumar, Kumar Surendra, Tyagi Asha
Department of Anaesthesiology and Critical Care, University College of Medical Sciences and GTB Hospital, Delhi, India.
J Anaesthesiol Clin Pharmacol. 2012 Jan;28(1):62-5. doi: 10.4103/0970-9185.92440.
When using morphine as the sole analgesic during conduct of anesthesia, the fear of its adverse postoperative effects primarily sedation and respiratory depression may impede adequate dosing and analgesia.
This audit aims to explore the dosing schedules of morphine used during general anesthesia in our institution and to analyze whether the fear of major side effects leads to suboptimal dosing of morphine with inadequate pain relief.
All subjects scheduled for surgery under general anesthesia wherein morphine was used exclusively for intraoperative analgesia were included in the audit. The audit proforma was completed by the attending anesthesiologist wherein the study period extended from beginning of anesthesia to immediate postoperative period.
The study population comprised of 158 patients having mean age 33 ± 14 years and mean weight 52 ± 14 kg. The dose of morphine administered at induction varied widely from 0.05 to 0.3 mg/kg i.v. The VAS (Visual Analogue Scale) score in immediate postoperative period varied from 0 to 10 (mean 1.7 ± 2.0) and sedation score from 1 to 5 (mean 3.94 ± 1.05). Inadequate analgesia with a VAS score ≥4 was seen in 15% patients. Morphine dosage of >0.1 mg/kg was associated with highly significant increase in quality of postoperative analgesia with VAS score <4, and an increase in sedation with sedation score ≤3 (P value < 0.01). However, none of the patients required active intervention for cardiorespiratory support.
The practice of dosing morphine in our institution is highly variable with doses ranging from 0.05 to 0.3 mg/kg. This results in inadequate analgesia in 15% patients in postoperative period. Titrating the dose of morphine to expected pain levels inflicted upon by surgical procedures may result in better pain control and less sedated patients postoperatively.
在麻醉过程中使用吗啡作为唯一的镇痛药时,对其术后不良反应(主要是镇静和呼吸抑制)的担忧可能会妨碍给予足够的剂量和镇痛效果。
本审计旨在探讨我院在全身麻醉期间使用吗啡的给药方案,并分析对主要副作用的担忧是否会导致吗啡给药剂量不足,从而使疼痛缓解不充分。
所有计划在全身麻醉下进行手术且术中仅使用吗啡进行镇痛的受试者均纳入本审计。审计表格由主治麻醉医生填写,研究期间从麻醉开始至术后即刻。
研究人群包括158例患者,平均年龄33±14岁,平均体重52±14千克。诱导时静脉注射吗啡的剂量差异很大,为0.05至0.3毫克/千克。术后即刻视觉模拟评分(VAS)为0至10分(平均1.7±2.0),镇静评分为1至5分(平均3.94±1.05)。15%的患者镇痛不充分,VAS评分≥4分。吗啡剂量>0.1毫克/千克与术后镇痛质量显著提高相关,VAS评分<4分,且镇静评分≤3分的镇静程度增加(P值<0.01)。然而,没有患者需要进行积极的心肺支持干预。
我院吗啡给药的做法差异很大,剂量范围为0.05至0.3毫克/千克。这导致15%的患者术后镇痛不充分。根据手术造成的预期疼痛水平调整吗啡剂量可能会在术后实现更好的疼痛控制,且患者镇静程度更低。